Detalles de la búsqueda
1.
Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy.
Eur J Clin Microbiol Infect Dis
; 43(4): 723-734, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38358552
2.
Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial.
Lancet Oncol
; 23(6): 818-828, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35654052
3.
Clinical and healthcare burden of disease associated with cytomegalovirus in allogeneic hematopoietic stem cell transplantation - A retrospective single-center study.
Transpl Infect Dis
; 24(6): e13947, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36082437
4.
Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia.
Blood
; 137(8): 1117-1120, 2021 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33027809
5.
Characterization of real-world treatment practices and outcomes among patients with chronic lymphocytic leukemia treated in a Finnish tertiary center.
EJHaem
; 3(1): 291-300, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35846189
6.
Protocol description of the HOVON 141/VISION trial: a prospective, multicentre, randomised phase II trial of ibrutinib plus venetoclax in patients with creatinine clearance ≥30 mL/min who have relapsed or refractory chronic lymphocytic leukaemia (RR-CLL) with or without TP53 aberrations.
BMJ Open
; 10(10): e039168, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33060089
7.
Early CD8+-recovery independently predicts low probability of disease relapse but also associates with severe GVHD after allogeneic HSCT.
PLoS One
; 13(9): e0204136, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30235281
Resultados
1 -
7
de 7
1
Próxima >
>>